Evidence map›Paper›PMID 25538794›Full record

ArticleGenome medicine2014

An integrated transcriptome and expressed variant analysis of sepsis survival and death.

Ephraim L Tsalik, Raymond J Langley, Darrell L Dinwiddie, Neil A Miller, Byunggil Yoo, Jennifer C van Velkinburgh, Laurie D Smith, Isabella Thiffault, Anja K Jaehne, Ashlee M Valente and 14 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Genome medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00258869 (Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP), which is not on this map. Cited by 62 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 4 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00258869 unknown statusnot on this map

Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP

TypeobservationalSponsorNational Center for Genome ResourcesRan2005 to 2010Enrolled1,200ConditionsSepsis, Septicemia, Sepsis Syndrome, Shock, Septic
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 4 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 9 institutions in 1 country.

Ephraim L TsalikEmergency Medicine Service, Durham Veterans Affairs Medical Center, Durham, North Carolina 27705 USA ; Department of Medicine, Duke University Medical Center, Durham, NC 27710 USA.
Raymond J LangleyNational Center for Genome Resources, Santa Fe, NM 87505 USA ; Department of Immunology, Lovelace Respiratory Research Institute, Albuquerque, NM 87108 USA.
Darrell L DinwiddieNational Center for Genome Resources, Santa Fe, NM 87505 USA ; Department of Pediatrics, Center for Translational Sciences, University of New Mexico, Albuquerque, NM 87131 USA.
Neil A MillerNational Center for Genome Resources, Santa Fe, NM 87505 USA ; Center for Pediatric Genomic Medicine, Children's Mercy Hospitals and Clinic, Kansas City, MO 64108 USA.
Byunggil YooCenter for Pediatric Genomic Medicine, Children's Mercy Hospitals and Clinic, Kansas City, MO 64108 USA.
Jennifer C van VelkinburghNational Center for Genome Resources, Santa Fe, NM 87505 USA.
Laurie D SmithCenter for Pediatric Genomic Medicine, Children's Mercy Hospitals and Clinic, Kansas City, MO 64108 USA.
Isabella ThiffaultCenter for Pediatric Genomic Medicine, Children's Mercy Hospitals and Clinic, Kansas City, MO 64108 USA.
Anja K JaehneDepartment of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan 48202 USA.
Ashlee M ValenteDepartment of Medicine, Duke University Medical Center, Durham, NC 27710 USA.
Ricardo HenaoDepartment of Electrical & Computer Engineering, Duke University, Durham, NC 27710 USA.
Xin YuanDepartment of Electrical & Computer Engineering, Duke University, Durham, NC 27710 USA.
Seth W GlickmanDepartment of Emergency Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599 USA.
Brandon J RiceNational Center for Genome Resources, Santa Fe, NM 87505 USA.
Micah T McClainDepartment of Medicine, Duke University Medical Center, Durham, NC 27710 USA ; Medicine Service, Durham Veterans Affairs Medical Center, Durham, NC 27705 USA.
Lawrence CarinDepartment of Electrical & Computer Engineering, Duke University, Durham, NC 27710 USA.
G Ralph CoreyDepartment of Medicine, Duke University Medical Center, Durham, NC 27710 USA ; Medicine Service, Durham Veterans Affairs Medical Center, Durham, NC 27705 USA.
Geoffrey S GinsburgDepartment of Medicine, Duke University Medical Center, Durham, NC 27710 USA.
Charles B CairnsDepartment of Emergency Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599 USA.
Ronny M OteroDepartment of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan 48202 USA ; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI 48109 USA.
Vance G FowlerDepartment of Medicine, Duke University Medical Center, Durham, NC 27710 USA.
Emanuel P RiversDepartment of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan 48202 USA.
Christopher W WoodsDepartment of Medicine, Duke University Medical Center, Durham, NC 27710 USA ; Medicine Service, Durham Veterans Affairs Medical Center, Durham, NC 27705 USA.
Stephen F KingsmoreNational Center for Genome Resources, Santa Fe, NM 87505 USA ; Department of Pediatrics, Center for Translational Sciences, University of New Mexico, Albuquerque, NM 87131 USA.
Children's Mercy Hospital · USDuke Medical Center · USNational Center for Genome Resources · USDuke University · USHenry Ford Hospital · USDurham VA Medical Center · USUniversity of North Carolina at Chapel Hill · USDuke University Hospital · USUniversity of New Mexico · US

Funding

ZUNI HEALTH INITIATIVE-PILOT STUDYP20RR016480 · NCRR · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI GRIFFITH, JEFFREY K · 2001 to 2011
$33.7M
Plasma Protein Biomarker-Based Diagnostics Of Outcome In Sepsis and CAPU01AI066569 · NIAID · NATIONAL CENTER FOR GENOME RESOURCES · PI KINGSMORE, STEPHEN FRANCIS · 2005 to 2010
$2.9M
Mentoring Patient Oriented Research in Antibiotic-Resistant BacteriaK24AI093969 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2011 to 2020
$1.6M
Detecting hospital-acquired infections using host gene-expression profilesIK2CX000530 · VA · DURHAM VA MEDICAL CENTER · PI TSALIK, EPHRAIM LEE · 2012 to 2014
–
CSRD VA IK2 CX000530NCRR NIH HHS P20 RR016480NIAID NIH HHS K24 AI093969NIAID NIH HHS U01 AI066569
6 · The paper itself

Abstract

backgroundSepsis, a leading cause of morbidity and mortality, is not a homogeneous disease but rather a syndrome encompassing many heterogeneous pathophysiologies. Patient factors including genetics predispose to poor outcomes, though current clinical characterizations fail to identify those at greatest risk of progression and mortality.

methodsThe Community Acquired Pneumonia and Sepsis Outcome Diagnostic study enrolled 1,152 subjects with suspected sepsis. We sequenced peripheral blood RNA of 129 representative subjects with systemic inflammatory response syndrome (SIRS) or sepsis (SIRS due to infection), including 78 sepsis survivors and 28 sepsis non-survivors who had previously undergone plasma proteomic and metabolomic profiling. Gene expression differences were identified between sepsis survivors, sepsis non-survivors, and SIRS followed by gene enrichment pathway analysis. Expressed sequence variants were identified followed by testing for association with sepsis outcomes.

resultsThe expression of 338 genes differed between subjects with SIRS and those with sepsis, primarily reflecting immune activation in sepsis. Expression of 1,238 genes differed with sepsis outcome: non-survivors had lower expression of many immune function-related genes. Functional genetic variants associated with sepsis mortality were sought based on a common disease-rare variant hypothesis. VPS9D1, whose expression was increased in sepsis survivors, had a higher burden of missense variants in sepsis survivors. The presence of variants was associated with altered expression of 3,799 genes, primarily reflecting Golgi and endosome biology.

conclusionsThe activation of immune response-related genes seen in sepsis survivors was muted in sepsis non-survivors. The association of sepsis survival with a robust immune response and the presence of missense variants in VPS9D1 warrants replication and further functional studies.

trial registrationClinicalTrials.gov NCT00258869. Registered on 23 November 2005.

Identifiers

PMID25538794
PMCPMC4274761
OpenAlexW2132270657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.